Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
FEBS Letters|June 28, 2005
Hsp27-2D-gel electrophoresis is a diagnostic tool to differentiate primary desminopathies from myofibrillar myopathiesChristoph S Clemen, Dirk Fischer, Udo Roth, et al.
Redox Biology|May 17, 2025
Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophyStephanie Kourakis, Cara A Timpani, Ryan M Bagaric, et al.
European Journal of Neurology|February 1, 2022
Spinal cord gray matter atrophy is associated with functional decline in post-polio syndromeMaria Janina Wendebourg, Matthias Weigel, Laura Richter, et al.
Human Molecular Genetics|March 7, 2003
On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondriaRolf Schröder, Bertrand Goudeau, Monique Casteras Simon, et al.
Neuromuscular Disorders : NMD|November 28, 2017
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysisSimone Schmidt, Patricia Hafner, Andrea Klein, et al.
Neuromuscular Disorders : NMD|May 11, 2006
Different early pathogenesis in myotilinopathy compared to primary desminopathyDirk Fischer, Christoph S Clemen, Montse Olivé, et al.
JCI Insight|September 26, 2023
Dimethyl fumarate modulates the dystrophic disease program following short-term treatmentCara A Timpani, Stephanie Kourakis, Danielle A Debruin, et al.
Neuromuscular Disorders : NMD|January 29, 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B)Bettina C Henzi, Niveditha Putananickal, Simone Schmidt, et al.
Brain : a Journal of Neurology|December 7, 2007
Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patientsRudolf A Kley, Yorck Hellenbroich, Peter F M van der Ven, et al.
Neuromuscular Disorders : NMD|February 15, 2026
Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trialGaëtan Zwingli, Niveditha Putananickal, Simone Schmidt, et al.
Pageof 10